Psychedelic clinical trials present unique challenges that can make successful execution fundamentally different from small molecules. The psychedelic experience, blinding, psychotherapy assistance and previous use, for example, introduce complexity that sponsors need to address early in the development process. Experienced cross-functional teams and sites with the right medical expertise, infrastructure and capabilities can help sponsors navigate these challenges.

In this webinar, the featured speakers will share complementary perspectives from CRO and site network organizations on what it takes to successfully design and execute psychedelic trials. The discussion will focus on three critical areas: translating the unique characteristics of psychedelics into thoughtful trial design, operationalizing complex studies at the site level and developing assessment strategies that support reliable and meaningful data. By bringing these perspectives together, the webinar will highlight strategies for anticipating challenges, strengthening study execution and building effective partnerships from the outset.

Ultimately, successful psychedelic development depends not only on a well-designed protocol, but on early collaboration with experienced partners who understand how to bring that protocol to life.

Register for this webinar to learn how psychedelic studies can be designed and executed to address trial complexity and support reliable study outcomes.

Contact the host of Executing Successful Psychedelic Studies from Protocol to Patient

There were 0 errors found in the information you submitted: